Subperiosteal Implants Constructed With Digital Technology
Launched by MANSOURA UNIVERSITY · Aug 22, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into a type of dental implant called subperiosteal implants, which are used for people who have lost bone in their jaw. Sometimes, when there isn’t enough bone to place traditional implants, subperiosteal implants can be considered as an option. This trial aims to see if using digital technology can improve the success of these implants, which were once thought to be outdated due to poor results.
To be eligible for this trial, participants should be adults aged between 18 and 80 years who have partial or complete tooth loss and meet specific bone conditions (Cawood and Howell class IV-VI). Participants will not be eligible if they need more complex surgeries involving bone grafts or other extensive procedures. Those who join the study can expect to receive treatment with the new subperiosteal implants and will help researchers learn more about their effectiveness. This could potentially offer a new option for people struggling with jawbone loss.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • population with partial or fully edentulous arches, in particular Cawood and Howell class (IV-VI);
- Exclusion Criteria:
- • Articles were excluded if complex reconstructive surgery including bone grafts, barrier membranes, jaw osteotomies, sinus lift, alveolar ridge distraction, and zygomatic implants was recommended for treatment
About Mansoura University
Mansoura University is a prestigious academic institution located in Egypt, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, it leverages its extensive resources and expertise in various fields of healthcare to facilitate innovative research initiatives aimed at improving patient outcomes. The university collaborates with a network of healthcare professionals and researchers to conduct high-quality clinical trials, focusing on addressing critical health challenges through rigorous scientific methodologies. Its dedication to ethical research practices and adherence to regulatory standards underscores its role as a leader in the medical research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Multiple Locations, , Egypt
Patients applied
Trial Officials
Mohammed ELSawy, PhD
Principal Investigator
Mansoura University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported